Kimmich F - Search Results

1

Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension.

Lanzl I, Hamacher T, Rosbach K, Ramez MO, Rothe R, Růžičková E, Karhanová M, Kimmich F. Lanzl I, et al. Among authors: kimmich f. Clin Ophthalmol. 2013;7:901-10. doi: 10.2147/OPTH.S41640. Epub 2013 May 16. Clin Ophthalmol. 2013. PMID: 23717036 Free PMC article.

2

Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension.

Erb C, Lanzl I, Seidova SF, Kimmich F. Erb C, et al. Among authors: kimmich f. Adv Ther. 2011 Jul;28(7):575-85. doi: 10.1007/s12325-011-0038-9. Epub 2011 Jun 30. Adv Ther. 2011. PMID: 21725844 Clinical Trial.

3

Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study.

Pillunat LE, Erb C, Ropo A, Kimmich F, Pfeiffer N. Pillunat LE, et al. Among authors: kimmich f. Clin Ophthalmol. 2017 Jun 2;11:1051-1064. doi: 10.2147/OPTH.S128453. eCollection 2017. Clin Ophthalmol. 2017. PMID: 28652689 Free PMC article.

4

Switching patients from preserved prostaglandin-analog monotherapy to preservative-free tafluprost.

Hommer A, Kimmich F. Hommer A, et al. Among authors: kimmich f. Clin Ophthalmol. 2011;5:623-31. doi: 10.2147/OPTH.S17876. Epub 2011 May 17. Clin Ophthalmol. 2011. PMID: 21629567 Free PMC article.

5

Treatment of patients with keratoconjunctivitis sicca with Optive: results of a multicenter, open-label observational study in Germany.

Kaercher T, Buchholz P, Kimmich F. Kaercher T, et al. Among authors: kimmich f. Clin Ophthalmol. 2009;3:33-9. Epub 2009 Jun 2. Clin Ophthalmol. 2009. PMID: 19668542 Free PMC article.

6

Micro-invasive glaucoma surgery (MIGS): a review of surgical procedures using stents.

Pillunat LE, Erb C, Jünemann AG, Kimmich F. Pillunat LE, et al. Among authors: kimmich f. Clin Ophthalmol. 2017 Aug 29;11:1583-1600. doi: 10.2147/OPTH.S135316. eCollection 2017. Clin Ophthalmol. 2017. PMID: 28919702 Free PMC article.

7

IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucoma.

Hommer A, Mohammed Ramez O, Burchert M, Kimmich F. Hommer A, et al. Among authors: kimmich f. Curr Med Res Opin. 2010 Aug;26(8):1905-13. doi: 10.1185/03007995.2010.492030. Curr Med Res Opin. 2010. PMID: 20553122 Clinical Trial.

8

Treatment of glaucoma patients with insufficient intraocular pressure control: a survey of German ophthalmologists in private practice.

Vorwerk C, Thelen U, Buchholz P, Kimmich F. Vorwerk C, et al. Among authors: kimmich f. Curr Med Res Opin. 2008 May;24(5):1295-301. doi: 10.1185/030079908x291976. Epub 2008 Mar 25. Curr Med Res Opin. 2008. PMID: 18366862

9

Treatment of patients with primary open-angle glaucoma with a fixed combination of brimonidine 0.2%/timolol 0.5%: multicenter, open-label, observational study in Germany.

Thelen U, Buchholz P, Kimmich F. Thelen U, et al. Among authors: kimmich f. Curr Med Res Opin. 2009 Apr;25(4):1003-9. doi: 10.1185/03007990902805916. Curr Med Res Opin. 2009. PMID: 19275517

10

Efficacy, tolerability and safety of the fixed combination of bimatoprost 0.03% and timolol 0.5% in a broad patient population: multicenter, open-label observational study.

Feuerhake C, Buchholz P, Kimmich F. Feuerhake C, et al. Among authors: kimmich f. Curr Med Res Opin. 2009 Apr;25(4):1037-43. doi: 10.1185/03007990902816947. Curr Med Res Opin. 2009. PMID: 19290780

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters